What is Michelle Corey?
Michelle Corey operates at the intersection of functional medicine and personalized health coaching, providing a specialized framework for individuals navigating complex autoimmune conditions such as Hashimoto's, lupus, and rheumatoid arthritis. The company distinguishes itself through a comprehensive service model that integrates one-on-one consulting, detailed video lab reviews, and structured self-paced learning modules. By focusing on the body's innate healing capacity, the organization has carved out a unique niche in the wellness sector, moving beyond symptomatic treatment to address the underlying physiological triggers of chronic illness. This market position is supported by a scalable digital infrastructure that allows for high-touch client engagement while maintaining operational efficiency.
How much funding has Michelle Corey raised?
Michelle Corey has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Michelle Corey
PPP
Public-Private Partnership
What's next for Michelle Corey?
With the recent infusion of capital, Michelle Corey is well-positioned to accelerate its operational scaling and broaden its service delivery capabilities. The strategic focus will likely shift toward enhancing the digital platform's diagnostic tools and expanding the practitioner network to accommodate a growing global client base. As the company matures through its current growth phase, the emphasis will remain on refining the proprietary root-cause methodology to ensure consistent clinical outcomes. Future initiatives may include the integration of advanced health-tracking technologies and the development of specialized programs for emerging autoimmune research, further cementing the company's authority in the functional health landscape.
See full Michelle Corey company page
